Research and development of medical artificial intelligence technology and information system for precise diagnosis and treatment of liver cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000036814

Enrollment

Unknown

Registered

2020-08-25

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cancer

Interventions

Gold Standard:Pathological and genetic data of hepatocellular carcinoma

Index test:Ultrasound

MRI

Eligibility

Sex/Gender

Male

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Fill in informed consent form; 2. Aged >=18 years old; 3. Patients with primary liver cancer confirmed by pathology and clinical examination; 4. Imaging examination: preoperative CT, Mr, US multimodal imaging examination; 5. Intervention therapy and follow-up results.

Exclusion criteria

Exclusion criteria: 1. Serious heart, lung, liver and kidney dysfunction; 2. Patients with contraindications such as cardiac pacemaker and cardiac stent in vivo; patients with allergy to contrast medium; 3. Patients with poor coordination during the examination, and image artifacts significantly affect the observation.

Design outcomes

Primary

Measure	Time frame
Genomic data of hepatocellular carcinoma;Multimodal imaging of liver cancer;Artificial intelligence diagnosis;	—

Countries

China

Contacts

Public ContactSong Wang

Longhua Hospital Affiliated to Shanghai University of traditional Chinese Medicine

wangsongws@163.com+86 18917763288

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026